Fingolimod Hydrochloride + Haloperidol Interaction
Majorinteraction on record
Description
QT-prolonging drug associated with torsades de pointes risk. Patients require overnight continuous ECG monitoring in medical facility during fingolimod initiation.
Mechanism
Additive QT prolongation and bradycardia-induced arrhythmia risk
Source: NLP:fingolimod hydrochloride